Dr. Campbell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4421 State Highway 6 S Ste 100
College Station, TX 77845Phone+1 979-690-4828Fax+1 979-690-4829
Education & Training
- Texas Tech University Health Sciences Center at LubbockResidency, Family Medicine, 2012 - 2015
- Texas Tech University Health Sciences Center School of MedicineClass of 2012
Certifications & Licensure
- TX State Medical License 2014 - 2025
- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma Start of enrollment: 2011 Nov 18
Press Mentions
- Alumna Named New Executive Director of the Callier Center for Communication DisordersJune 25th, 2020
- Former U-M Football Player Says Going Vegan Changed His Life, Reversed DiabetesMarch 10th, 2016
Grant Support
- Colorado AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2007–2012
- Programmatic: Novel Education Clinical Trainees And Researchers (NECTAR) ProgramFogarty International Center2010–2011
- Colorado HIV Research Training ProgramNational Institute Of Allergy And Infectious Diseases2007–2011
- AdministrativeNational Institute Of Allergy And Infectious Diseases2008
- U Of Colorado Center For AIDS ResearchNational Institute Of Allergy And Infectious Diseases2007–2008
- Significance Of Oral KS In An African SettingNational Institute Of Dental &Craniofacial Research2005–2006
- University Of Colorado HIV Research Training ProgramNational Institute Of Allergy And Infectious Diseases2004–2006
- Colorado Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2004–2006
- Human Herpesvirus 8 Infection In ZimbabweFogarty International Center1999–2001
- Inhibition Of HHV 8 Gene Expression By RibozymesNational Cancer Institute1998–2001
- Factors That Affect The Activity Of Antihiv RibozymesNational Institute Of General Medical Sciences1997–1999
- In Vivo Selection Of Anti-Hiv-1 RibozymesNational Institute Of Allergy And Infectious Diseases1993–1997
- Resistance Of HIV-1 To Anti-Retroviral AgentsNational Institute Of Allergy And Infectious Diseases1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: